Taxpayers Helped Fund This $129,000 Cancer Drug. Should the Government Help Cut the Price?

January 14, 2016

(The Washington Post) – Two nonprofit groups have petitioned the federal government to take actions to increase the competition for a cancer drug that costs $129,269 a year by exercising its right to step in if the fruits of taxpayer-funded research are not “available to the public on reasonable terms,” according to U.S. law.